Instrumento Inactivo

Acciones Omthera Pharmaceuticals Inc

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Omthera Pharmaceuticals Inc : FDA accepts new drug application for investigational compound Epanova for the treatment of severe hypertriglyceridaemia	20/09/13
Omthera Pharmaceuticals Inc : Omthera Stockholders Approve Acquisition by AstraZeneca	16/07/13
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces NDA Submission for Epanova(TM) for the Treatment of Patients with Very High Triglycerides	09/07/13
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period	27/06/13
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders	13/06/13

Sector

	Varia. 1 de ene.	Capi.
MERCK KGAA	+7,39 %	72,09 mil M
KYOWA KIRIN CO. LTD.	+15,93 %	9045,31 M
YUHAN CORPORATION	+17,59 %	4392,25 M
SK BIOPHARMACEUTICALS CO., LTD.	-22,81 %	4404,41 M
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+25,93 %	3936,43 M
INDIVIOR PLC	+4,64 %	2100,04 M
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+9,09 %	1971,09 M
BETTA PHARMACEUTICALS CO., LTD.	-36,86 %	1874,49 M
VELOXIS PHARMACEUTICALS A/S	-0,50 %	1644,13 M